Unlock instant, AI-driven research and patent intelligence for your innovation.

Preparation method for 4-(4-cyclopropyl-naphthalene-1-yl)-5-thio-[1,2,4]triazolidine-3-ketone and intermediate 4-cyclopropyl-naphthalene-1-yl-ethyl carbamate

An intermediate, cyclopropyl technology, which is applied in the field of intermediate (4-cyclopropylnaphthalen-1-yl)-ethyl carbamate and its preparation, can solve the problem of long synthetic route, large environmental impact and difficult operation. Convenience and other issues

Inactive Publication Date: 2015-11-04
ANHUI WANBANG MEDICAL TECH
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Foreign patents WO2009070740A2, US2010056464A1, WO2011085009A2 and related patents report the synthesis route of Lesinurad, but most of these methods use thiophosgene, which is not easy for large-scale production
Chinese patent CN102040546A starts from 4-cyclopropyl-1-naphthaldehyde and synthesizes Lesinurad intermediate isocyanate in three steps. This method has a long synthetic route and low overall yield.
The Chinese patent uses 4-cyclopropyl-1-naphthylamine as the starting material to synthesize Lesinurad. This "naphthylamine method" is extremely inconvenient to operate, has a great impact on the environment, and has high labor protection costs.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method for 4-(4-cyclopropyl-naphthalene-1-yl)-5-thio-[1,2,4]triazolidine-3-ketone and intermediate 4-cyclopropyl-naphthalene-1-yl-ethyl carbamate
  • Preparation method for 4-(4-cyclopropyl-naphthalene-1-yl)-5-thio-[1,2,4]triazolidine-3-ketone and intermediate 4-cyclopropyl-naphthalene-1-yl-ethyl carbamate
  • Preparation method for 4-(4-cyclopropyl-naphthalene-1-yl)-5-thio-[1,2,4]triazolidine-3-ketone and intermediate 4-cyclopropyl-naphthalene-1-yl-ethyl carbamate

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0022] Example 1: Preparation of (4-cyclopropylnaphthalen-1-yl)-urethane

[0023] Weigh (17.5 g; 197 mmol) ethyl carbamate, (58.6 g; 236 mmol) 4-cyclopropyl-1-bromonaphthalene, (6.2 g; 10% mmol) CuI 2 , (81.6 g; 3 eq) K 2 CO 3 , (5.7 g; 20% mmol) 8-hydroxyquinoline was added to a 500 mL three-necked flask, 140 mL of toluene was added, under nitrogen protection, the temperature was raised to reflux, and the reaction was tracked by LC. The raw material was less than 3% in about 18 h, and the reaction liquid was cooled to about 30 °C, filter out the insoluble matter, transfer the filtrate to a 1000 mL three-neck flask, drop the reaction solution into 10 °C, add 400 mL of purified water, stir at 10 °C for 1.5 h, filter with suction, wash with 200 mL of purified water for two Once, dried in vacuo at 80 ℃ to obtain 32.7 g of off-white solid with a yield of 65%.

Embodiment 2

[0024] Example 2: Preparation of 4-(4-cyclopropylnaphthalen-1-yl)-5-thio-[1,2,4]triazolidin-3-one

[0025] Weigh (5.2 g; 20 mmol) (4-cyclopropylnaphthalen-1-yl)-urethane, (7.6 g; 100 mmol) CS 2 , (6.1 g; 3eq) TEA was added to a 100 mL single-necked bottle, 50 mL of toluene was added, and the reaction was stirred at 35-40 °C. After LC tracking, the raw material was completely converted in about 24 h, filtered with suction, washed twice with 25 mL of toluene, 35 Vacuum-dry at ℃ for 2 hours, take out the solid, put all into a 100 mL single-necked bottle, add (2.1 g; 20 mmol) hydrazine dihydrochloride, (10.3 g; 5 eq) diethylenetriamine, wash the hydrazine dihydrochloride completely with 50 mL toluene Add in, heat up to 80 °C, stir for 4 h, cool the reaction solution to 10 °C, add 30 mL of 1N hydrochloric acid dropwise, stir for 5 h, filter with suction, wash 3 times with 50 mL of purified water, and vacuum-dry at 80 °C to obtain an off-white solid 4.5 g, yield 85%.

Embodiment 3

[0026] Example 3: Preparation of 4-(4-cyclopropylnaphthalen-1-yl)-5-thio-[1,2,4]triazolidin-3-one

[0027] Weigh (5.2 g; 20 mmol) (4-cyclopropylnaphthalen-1-yl)-urethane, (3.8 g; 50 mmol) CS 2 , (6.1 g; 3eq) TEA was added to a 100 mL single-necked bottle, 50 mL of toluene was added, and the reaction was stirred at 35-40 °C. After LC tracking, the raw material was completely converted in about 24 h, filtered with suction, washed twice with 25 mL of toluene, 35 Vacuum-dry at ℃ for 2 hours, take out the solid, put all into a 100 mL single-necked bottle, add (2.1 g; 20 mmol) hydrazine dihydrochloride, (10.3 g; 5 eq) diethylenetriamine, wash the hydrazine dihydrochloride completely with 50 mL toluene Add in, heat up to 80 °C, stir for 4 h, cool the reaction solution to 10 °C, add 30 mL of 1N hydrochloric acid dropwise, stir for 5 h, filter with suction, wash 3 times with 50 mL of purified water, and vacuum-dry at 80 °C to obtain an off-white solid 2.2 g, yield 40%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides a preparation method for 4-(4-cyclopropyl-naphthalene-1-yl)-5-thio-[1,2,4]triazolidine-3-ketone and an intermediate 4-cyclopropyl-naphthalene-1-yl-ethyl carbamate. The intermediate is used for synthesis of an anti-gout drug Lesinurad, and has the advantages of being economic, environmentally friendly, high in effectiveness, and high in yield.

Description

technical field [0001] The invention relates to an intermediate 4-(4-cyclopropylnaphthalene-1-yl)-5-thio-[1,2,4]triazolidin-3-one used in the synthesis of anti-gout drug Lesinurad and its preparation Methods, intermediate (4-cyclopropylnaphthalen-1-yl)-ethyl carbamate and method for its preparation. Background technique [0002] Gout is a crystal-associated arthropathy caused by the precipitation of monosodium urate (MSU), which is directly related to hyperuricemia caused by disturbance of purine metabolism and decreased uric acid excretion. It is an oral drug that promotes uric acid excretion and can inhibit the renal proximal tubule uric acid transporter URAT1; Lesinurad (RDEA594) is also a xanthine oxidase inhibitor, which is approved for the treatment of hyperuricemia in gout, and the combined treatment of Lesinurad and Febuxostat Well tolerated and markedly lowers uric acid. [0003] Foreign patents WO2009070740A2, US2010056464A1, WO2011085009A2 and related patents re...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D249/12C07C271/30C07C269/06
CPCC07D249/12C07C269/06C07C271/30
Inventor 易加明陶春蕾邵凤杨欣怡束超徐怀友
Owner ANHUI WANBANG MEDICAL TECH